The acquisition includes Informa's full portfolio of specialist brands which includes the Citeline suite of products, Trialtrove, Sitetrove, Pharmaprojects and Citeline branded products, as well as Biomedtracker, Clinerion, Datamonitor Healthcare, Pink Sheet, Scrip, Skipta, and TrialScope. The acquisition is expected to complete within the first half of 2022, subject to any relevant regulatory clearances. Its publications and data are well represented in Dow Jones Factiva and LexisNexis
from Infotoday.eu RSS Feeds : Featured News https://ift.tt/sc92jmL
https://ift.tt/KAVxdj5
Post a Comment
If you have any doubts. Let me know